Abicee Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 30-11-2024
- Paid Up Capital ₹ 0.90 M
as on 30-11-2024
- Company Age 40 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.40 Cr
as on 30-11-2024
- Satisfied Charges ₹ 6.33 M
as on 30-11-2024
- Revenue -7.55%
(FY 2023)
- Profit 29.32%
(FY 2023)
- Ebitda 117.79%
(FY 2023)
- Net Worth 10.08%
(FY 2023)
- Total Assets -29.57%
(FY 2023)
About Abicee Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 0.90 M.
The company currently has active open charges totaling ₹4.40 Cr. The company has closed loans amounting to ₹6.33 M, as per Ministry of Corporate Affairs (MCA) records.
Subhash Sahu, Shekhar Sahu, Sandeep Sahu, and One other member serve as directors at the Company.
- CIN/LLPIN
U15549OR1984PTC001404
- Company No.
001404
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Aug 1984
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Khorda, Odisha, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Abicee Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subhash Sahu  | Director | 08-Feb-2013 | Current |
| Shekhar Sahu | Director | 29-Aug-2019 | Current |
| Sandeep Sahu | Director | 08-Feb-2013 | Current |
| Shubhra Sahu | Director | 15-Jan-2013 | Current |
Financial Performance of Abicee Pharmaceuticals.
Abicee Pharmaceuticals Pvt Ltd, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.55% decrease. The company also saw a substantial improvement in profitability, with a 29.32% increase in profit. The company's net worth Soared by an impressive increase of 10.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Abicee Pharmaceuticals?
Unlock access to Abicee Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Umeri Distillery Private LimitedActive 39 years 10 monthsSubhash Sahu and Sandeep Sahu are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 18 Feb 2022 | ₹4.40 Cr | Open |
Bank Of India Creation Date: 10 Jan 2007 | ₹2.80 M | Satisfied |
Small Industries Development Bank Of India Creation Date: 10 Nov 2004 | ₹2.40 M | Satisfied |
How Many Employees Work at Abicee Pharmaceuticals?
Abicee Pharmaceuticals has a workforce of 30 employees as of Nov 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Abicee Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abicee Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
